• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immune response to influenza A (H1N1) monovalent MF59-adjuvanted vaccine in HIV-infected patients

tetano

Editor, Senior Moderator
Vaccine. 2011 Feb 21. [Epub ahead of print]
Immune response to influenza A (H1N1) monovalent MF59-adjuvanted vaccine in HIV-infected patients.

Fabbiani M, Di Giambenedetto S, Sali M, Farina S, Sansonetti P, Tamburrini E, Verme LZ, Delogu G, De Luca A, Kelvin D, Cauda R, Fadda G.

Institute of Clinical Infectious Diseases, Catholic University of Sacred Heart, Largo F. Vito 1, 00168 Rome, Italy.
Abstract

Immunogenicity of influenza A (H1N1)v MF59-adjuvanted vaccine was studied in HIV-infected patients. The vaccine was effective in inducing a protective immune response in patients with a CD4 >200cells/μL while individuals with CD4 <200cells/μL showed lower rates of seroconversion and seroprotection. These results underscore the usefulness of immunization against influenza in HIV-infected patients, though a boosting dose of vaccine may be required in seriously immunocompromised patients.
Copyright ? 2011. Published by Elsevier Ltd.

PMID: 21349364 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21349364
 
Back
Top Bottom